
浏览全部资源
扫码关注微信
1.河南中医药大学骨伤学院(河南 郑州 450003)
2.河南中医药大学附属郑州中医骨伤病医院骨关节科;(河南 郑州 450016)
段誉,男,硕士研究生,主要从事中医药防治骨关节病与运动损伤研究工作
曹玉举,主任医师,硕士研究生导师; E-mail:caoyuju@126.com
收稿日期:2024-12-10,
纸质出版日期:2025-09-10
移动端阅览
段誉,曹玉举,王子昂.中医药治疗骨质疏松合并高脂血症研究进展[J].上海中医药杂志,2025,59(9):96-100.
DUAN Yu,CAO Yuju,WANG Ziang.Research progress on traditional Chinese medicine in treating osteoporosis complicated with hyperlipidemia[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(9):96-100.
段誉,曹玉举,王子昂.中医药治疗骨质疏松合并高脂血症研究进展[J].上海中医药杂志,2025,59(9):96-100. DOI: 10.16305/j.1007-1334.2025.z20241210004.
DUAN Yu,CAO Yuju,WANG Ziang.Research progress on traditional Chinese medicine in treating osteoporosis complicated with hyperlipidemia[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(9):96-100. DOI: 10.16305/j.1007-1334.2025.z20241210004.
骨质疏松与高脂血症作为两种广泛存在的代谢性疾病,常相伴发生。根据中医经典认识与疾病发病特点,将骨质疏松合并高脂血症的病机归纳为正虚邪实,即以脾肾两虚为本,痰湿、瘀血为标,并从中药单品、药对、复方应用,以及穴位敷贴、针灸等非药物疗法等方面梳理中医药治疗骨质疏松与高脂血症的相关研究,以期为临床实践提供参考。
Osteoporosis and hyperlipidemia are two widely prevalent metabolic diseases that often occur concurrently. According to classical understanding of traditional Chinese medicine (TCM) and the characteristics of the diseases, the pathogenesis of osteoporosis complicated with hyperlipidemia is summarized as a pattern of deficiency of the healthy qi and excess of pathogenic qi. The root cause is dual deficiency of spleen and kidney, with manifestations including phlegm, dampness, and blood stasis. To provide clinical reference for practice, this paper reviews relevant research on the TCM for treating osteoporosis complicated with hyperlipidemia, including the application of single herbs, herb pairs, compound formulas, as well as non-pharmacological therapies such as acupoint applications, acupuncture and moxibustion.
中华医学会物理医学与康复学分会 . 骨质疏松症康复治疗指南(2024版) [J]. 中国循证医学杂志 , 2024 , 24 ( 6 ): 626 - 636 .
颜伟泓 , 张鸿燕 , 李玲燕 , 等 . 泽泻醇A对HepG2细胞脂质沉积的影响及其降脂活性研究 [J]. 上海中医药杂志 , 2024 , 58 ( 10 ): 63 - 70 .
HAN H , LI R , FU D , et al . Correlation between bone density, bone metabolism markers with lipid metabolism markers and body mass index [J]. BMC Musculoskelet Disord , 2024 , 25 ( 1 ): 162 .
ZHANG Z , DUAN Y , HUO J . lipid metabolism,methylation aberrant,and osteoporosis:a multi-omics study based on Mendelian randomization [J]. Calcif Tissue Int , 2024 , 114 ( 2 ): 147 - 156 .
LORENTZON M , ABRAHAMSEN B . Osteoporosis epidemiology using international cohorts [J]. Curr Opin Rheumatol , 2022 , 34 ( 5 ): 280 - 288 .
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration . Familial hypercholesterolaemia in children and adolescents from 48 countries:a cross-sectional study [J]. Lancet , 2024 , 403 ( 10421 ): 55 - 66 .
叶良策 , 万瑾 , 康骏 , 等 . 从“浊”探析高脂血症的中医病机及治疗 [J]. 江西中医药 , 2022 , 53 ( 8 ): 14 - 16 .
魏博 , 蒋宜伟 , 李娟 , 等 . 高脂血症与骨质疏松的相关性研究进展 [J]. 医学研究杂志 , 2022 , 51 ( 12 ): 10 - 13 .
杨五洲 , 曹奇 , 唐朝克 . 高脂血症与骨质疏松 [J]. 中国动脉硬化杂志 , 2016 , 24 ( 3 ): 321 - 324 .
黄凤林 , 张宝瑜 , 周洪波 . 《黄帝内经》中治疗骨质疏松经验 [J]. 世界中医药 , 2022 , 17 ( 3 ): 424 - 426 .
柏帆 , 唐露霖 , 尚文斌 . 高脂血症的中医分类治疗探讨 [J]. 中医药学报 , 2022 , 50 ( 2 ): 10 - 13 .
侯承志 , 陈兴娟 , 胡木 , 等 . 冯玲教授从“因郁致浊”论治高脂血症的经验探析 [J]. 中国医药导报 , 2022 , 19 ( 13 ): 123 - 126 .
蒋廷 , 程丹 , 吴玲 , 等 . 李明权从脾虚痰浊论治高脂血症经验 [J]. 山西中医 , 2021 , 37 ( 5 ): 9 - 10 .
王振兴 , 杨金梅 , 张志斌 , 等 . 绞股蓝的化学成分及其生物活性研究进展 [J]. 南方农业学报 , 2023 , 54 ( 6 ): 1741 - 1752 .
孔源 , 王莹 , 姜瑾 , 等 . 绞股蓝总苷对高脂诱导ApoE -/- 小鼠致动脉粥样硬化伴骨质疏松骨密度、骨小梁及骨代谢的影响 [J]. 辽宁中医药大学学报 , 2021 , 23 ( 12 ): 26 - 30 .
崔馨月 , 贾连群 , 杨关林 , 等 . 绞股蓝总苷对骨质疏松合并动脉粥样硬化小鼠的防治作用 [J]. 中华中医药学刊 , 2022 , 40 ( 9 ): 193 - 196 .
李婉玉 , 张家旭 , 谢兴文 , 等 . 杜仲叶化学成分、药理活性及现代应用研究进展 [J]. 天然产物研究与开发 , 2024 , 36 ( 5 ): 900 - 917 .
ZHENG Y , XIAO Y , ZHANG D , et al . Geniposide ameliorated dexamethasone-induced cholesterol accumulation in osteoblasts by mediating the GLP-1R/ABCA1 axis [J]. Cells , 2021 , 10 ( 12 ): 3424 .
罗兰兰 , 张宇静 , 任明诗 , 等 . 杜仲汤对去卵巢大鼠骨质疏松症的影响及机制研究 [J]. 中药新药与临床药理 , 2024 , 35 ( 4 ): 461 - 468 .
余成馨 , 王海帆 , 王鹏 , 等 . 杜仲叶提取物对高脂血症模型大鼠降脂作用及肠道菌群影响研究 [J]. 中药药理与临床 , 2023 , 39 ( 9 ): 55 - 61 .
丁劼 , 王晗松 , 王培歌 , 等 . 丹参主要活性成分防治骨质疏松症分子机制研究进展 [J]. 中国骨质疏松杂志 , 2022 , 28 ( 5 ): 770 - 775 .
梅凡 , 涂艳虹 . 丹参注射液对骨质疏松合并动脉粥样硬化症小鼠的作用研究 [J]. 中国骨质疏松杂志 , 2021 , 27 ( 3 ): 348 - 352 .
WANG S , YUAN Y , LIN Q , et al . Antiosteoporosis effect of tanshinol in osteoporosis animal models:A systematic review and meta-analysis [J]. Front Pharmacol , 2022 , 13 : 937538 .
张玉昆 , 冯月男 , 卞敬琦 , 等 . 基于蛋白质组学探讨丹参饮对高脂血症模型大鼠血小板活化的影响机制 [J]. 中国实验方剂学杂志 , 2024 , 30 ( 8 ): 1 - 8 .
李莉 , 王嘉瑞 , 王晶 , 等 . 淫羊藿的主要化学成分、药理作用研究进展及质量标志物的预测分析 [J]. 中华中医药学刊 , 2023 , 41 ( 11 ): 143 - 151 .
XUE L , JIANG Y , HAN T , et al . Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim [J]. J Ethnopharmacol , 2016 , 192 : 370 - 381 .
许世超 , 冯艺昕 , 黄展辉 , 等 . 从PGC1-α/FNDC5/UCP1信号通路探讨淫羊藿苷对FNDC5基因敲除小鼠脂代谢的影响 [J]. 时珍国医国药 , 2022 , 33 ( 4 ): 850 - 853 .
BAI L , LIU Y , ZHANG X , et al . Osteoporosis remission via an anti-inflammaging effect by icariin activated autophagy [J]. Biomaterials , 2023 , 297 : 122125 .
ZHANG Y , MA J , ZHANG W . Berberine for bone regeneration:Therapeutic potential and molecular mechanisms [J]. J Ethnopharmacol , 2021 , 277 : 114249 .
CHEN Q C , PU Y L , BI J , et al . Protective effects of berberine on senile osteoporosis in mice [J]. J Bone Miner Metab , 2021 , 39 ( 5 ): 748 - 756 .
GU S , WANG J , YU S , et al . Berberine ameliorates nonalcoholic fatty liver disease-induced bone loss by inhibiting ferroptosis [J]. Bone , 2024 , 185 : 117114 .
LU L , WANG Z , ZHANG H , et al . Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation [J]. Gynecol Endocrinol , 2022 , 38 ( 2 ): 176 - 180 .
SUN J , PAN Y , LI X , et al . Quercetin attenuates osteoporosis in orchiectomy mice by regulating glucose and lipid metabolism via the GPRC6A/AMPK/mTOR signaling pathway [J]. Front Endocrinol(Lausanne) , 2022 , 13 : 849544 .
VIANA F S , PEREIRA J A , CRESPO T S , et al . Oral supplementation with resveratrol improves hormonal profile and increases expression of genes associated with thermogenesis in oophorectomy mice [J]. Mol Cell Endocrinol , 2024 , 591 : 112268 .
仇业鹏 , 张庭然 . 跑步运动配合银杏叶提取物摄入对去卵巢肥胖骨质疏松大鼠骨密度、血脂和抗氧化能力影响研究 [J]. 中国骨质疏松杂志 , 2019 , 25 ( 3 ): 343 - 350 .
LI B , WANG Y , GONG S , et al . Puerarin improves OVX-induced osteoporosis by regulating phospholipid metabolism and biosynthesis of unsaturated fatty acids based on serum metabolomics [J]. Phytomedicine , 2022 , 102 : 154198 .
DONG X L , YU W X , LI C M , et al . Chuanxiong (Rhizome of Ligusticum chuanxiong ) protects ovariectomized hyperlipidemic rats from bone loss [J]. Am J Chin Med , 2020 , 48 ( 2 ): 463 - 485 .
邢菊玲 , 党院霞 , 刘芬 , 等 . 桑白皮总黄酮联合知母总皂苷改善高脂血症伴骨质疏松症大鼠的作用机制 [J]. 中国实验方剂学杂志 , 2021 , 27 ( 2 ): 37 - 43 .
PARK D , YOON J E , CHOI B , et al . Complex extract of Polygonatum sibiricum and Nelumbinis semen improves menopause symptoms via regulation of estrogen receptor beta in an ovariectomized rat model [J]. Nutrients , 2023 , 15 ( 11 ): 2443 .
王文佳 , 闫静静 , 陈景利 , 等 . 三七总皂苷联合葛根总黄酮对高脂血症合并骨质疏松大鼠的改善作用及机制 [J]. 中国老年学杂志 , 2023 , 43 ( 9 ): 2248 - 2252 .
张妍 , 向楠 , 周广文 , 等 . 补肾化痰方对去势骨质疏松大鼠脂骨代谢的影响及中枢调控机制研究 [J]. 中华中医药学刊 , 2022 , 40 ( 5 ): 21 - 27 .
张倩 , 杨旭 , 王媛 , 等 . 金匮肾气丸对去势大鼠骨微结构及ALP、OPG、IL-6的影响 [J]. 中国骨质疏松杂志 , 2020 , 26 ( 10 ): 1475 - 1480 .
舒高 , 宋晓飞 , 张轲 , 等 . 温肾固疏方对绝经后骨质疏松大鼠骨代谢以及脂代谢的影响 [J]. 中国骨质疏松杂志 , 2018 , 24 ( 11 ): 1498 - 1501 .
娄妍 , 余旭 , 孙心怡 , 等 . 探讨芪葵颗粒干预2型糖尿病合并骨质疏松大鼠的实验研究 [J]. 西部中医药 , 2022 , 35 ( 6 ): 25 - 28 .
WEN J , BAO Z , LI L , et al . Qiangguyin inhibited fat accumulation in OVX mice through the p38 MAPK signaling pathway to achieve anti-osteoporosis effects [J]. Biomed Pharmacother , 2023 , 158 : 114122 .
孙平 , 虎松艳 , 巫培康 , 等 . 复方贞术调脂胶囊对糖皮质激素诱导骨质疏松大鼠血脂和骨转换指标的研究 [J]. 中国骨质疏松杂志 , 2016 , 22 ( 10 ): 1308 - 1310 .
姜宜妮 , 梁健 , 闵建新 , 等 . 二至丸对绝经后骨质疏松鼠的作用观察及可能机制研究 [J]. 世界中医药 , 2020 , 15 ( 21 ): 3255 - 3259 .
DAI X , LIU Y , LIU T , et al . SiJunZi decoction ameliorates bone quality and redox homeostasis and regulates advanced glycation end products/receptor for advanced glycation end products and WNT/β-catenin signaling pathways in diabetic mice [J]. J Ethnopharmacol , 2024 , 319 ( Pt 2 ): 117167 .
SHI N , ZHAO C , FANG C , et al . Effects of acupoint catgut embedding on the postmenopausal osteoporosis patients and related mechanism [J]. Am J Transl Res , 2021 , 13 ( 3 ): 1789 - 1798 .
QIU J , XU J , CAI Y , et al . Catgut embedding in acupoints combined with repetitive transcranial magnetic stimulation for the treatment of postmenopausal osteoporosis: study protocol for a randomized clinical trial [J]. Front Neurol , 2024 , 15 : 1295429 .
YIN N , WU X , REN R , et al . The effect of acupoint catgut embedding and drug therapy on hyperlipidemia:a meta-analysis of randomized controlled trials [J]. Biotechnol Genet Eng Rev , 2024 , 40 ( 1 ): 664 - 677 .
JIN S W , HAN Y L , PAN X L , et al . Electroacupuncture regulates hepatic cholesterol synthesis by HMGCR deubiquitination in rats [J]. Heliyon , 2023 , 9 ( 10 ): e21005 .
LIU J , ZHOU J , WANG J , et al . Electroacupuncture ameliorates senile osteoporosis by promoting bone remodeling and regulating autophagy [J]. Acupunct Med , 2024 , 42 ( 5 ): 260 - 267 .
姚长风 , 刘自兵 , 唐巍 , 等 . 艾灸对去卵巢骨质疏松症大鼠骨髓间充质干细胞Wnt/β-catenin信号通路的影响 [J]. 安徽中医药大学学报 , 2020 , 39 ( 2 ): 54 - 58 .
XU Q , WU H , ZHU H , et al . Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathway [J]. Heliyon , 2023 , 9 ( 5 ): e15316 .
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构
沪公网安备 31011502015228号